Banca Mediolanum (BMED) Stock Overview
Engages in the provision of various banking products and services in Italy. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 5/6 |
BMED Community Fair Values
Create NarrativeSee what 18 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Banca Mediolanum S.p.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €21.60 |
| 52 Week High | €22.26 |
| 52 Week Low | €14.24 |
| Beta | 0.75 |
| 1 Month Change | 9.04% |
| 3 Month Change | 25.36% |
| 1 Year Change | 48.15% |
| 3 Year Change | 160.81% |
| 5 Year Change | 162.26% |
| Change since IPO | 195.49% |
Recent News & Updates
Narrative Update • Jun 22
BMED: Future Returns Will Rely On Revenue Assumptions And Discount Rate
The analyst price target for Banca Mediolanum has been adjusted slightly higher to €22.07 from €21.96, with analysts pointing to updated assumptions on revenue growth, profit margins and the future P/E as the key drivers behind the change. What's in the News for Banca Mediolanum No major recent news items for Banca Mediolanum were identified in the provided sources.Narrative Update • Jun 07
BMED: Future Upside Will Rely On Lower Discount Rate Assumptions
The updated analyst price target for Banca Mediolanum is now €21.96, the same as the previous target of €21.96. This reflects analysts fine tuning their assumptions around revenue growth, profit margins and the future P/E multiple.Narrative Update • May 21
BMED: Future Upside Will Rely On Lower Discount Rate Assumptions
Analysts have nudged their price target for Banca Mediolanum higher from €21.43 to €21.96, citing updated assumptions that include a slightly lower discount rate, modestly adjusted revenue growth expectations, a small uplift in projected profit margins, and a marginally lower future P/E multiple. Valuation Changes Fair value has been updated slightly higher from €21.43 to €21.96.Narrative Update • Apr 25
BMED: Future Upside Will Depend On Discount Rate And P/E Assumptions
Analysts have nudged their price target on Banca Mediolanum higher to €20.50, supported by updated assumptions around discount rates, revenue growth, profit margins and future P/E, which slightly adjust fair value to about €21.43. Analyst Commentary Analysts lifting the price target to €20.50 are effectively signaling more confidence that the current assumptions for Banca Mediolanum's earnings and valuation can support a higher fair value, while still leaving a modest gap to the internally assessed value of about €21.43.Recent updates
Narrative Update • Jun 22
BMED: Future Returns Will Rely On Revenue Assumptions And Discount Rate
The analyst price target for Banca Mediolanum has been adjusted slightly higher to €22.07 from €21.96, with analysts pointing to updated assumptions on revenue growth, profit margins and the future P/E as the key drivers behind the change. What's in the News for Banca Mediolanum No major recent news items for Banca Mediolanum were identified in the provided sources.Narrative Update • Jun 07
BMED: Future Upside Will Rely On Lower Discount Rate Assumptions
The updated analyst price target for Banca Mediolanum is now €21.96, the same as the previous target of €21.96. This reflects analysts fine tuning their assumptions around revenue growth, profit margins and the future P/E multiple.Narrative Update • May 21
BMED: Future Upside Will Rely On Lower Discount Rate Assumptions
Analysts have nudged their price target for Banca Mediolanum higher from €21.43 to €21.96, citing updated assumptions that include a slightly lower discount rate, modestly adjusted revenue growth expectations, a small uplift in projected profit margins, and a marginally lower future P/E multiple. Valuation Changes Fair value has been updated slightly higher from €21.43 to €21.96.Narrative Update • Apr 25
BMED: Future Upside Will Depend On Discount Rate And P/E Assumptions
Analysts have nudged their price target on Banca Mediolanum higher to €20.50, supported by updated assumptions around discount rates, revenue growth, profit margins and future P/E, which slightly adjust fair value to about €21.43. Analyst Commentary Analysts lifting the price target to €20.50 are effectively signaling more confidence that the current assumptions for Banca Mediolanum's earnings and valuation can support a higher fair value, while still leaving a modest gap to the internally assessed value of about €21.43.Narrative Update • Apr 10
BMED: Future Upside Will Hinge On Discount Rate And P/E Confidence
Analysts have lifted their price target on Banca Mediolanum to €20.50 from €19.40, pointing to updated assumptions around the discount rate, revenue growth and future P/E that refine their view of the bank's valuation. Analyst Commentary Analysts increasing the price target to €20.50 highlight a tighter focus on how discount rates, revenue assumptions and future P/E expectations feed into Banca Mediolanum's valuation.Narrative Update • Mar 27
BMED: Future Upside Will Rely On Margin Strength And Supportive P/E Levels
Analysts have trimmed their fair value estimate for Banca Mediolanum from about €21.55 to roughly €21.52, a modest adjustment that follows a recent Street price target increase to €20.50 and reflects slightly updated assumptions on discount rate, revenue growth, profit margin, and future P/E. Analyst Commentary Recent Street research, including the price target adjustment to €20.50, gives you a clearer view of how analysts are framing Banca Mediolanum’s risk and reward trade off at current levels.Narrative Update • Mar 11
BMED: Future Upside Will Depend On Margin Strength And Supportive P/E
Analysts have raised their price target on Banca Mediolanum to €20.50 from €19.40, citing updated views on discount rates, profit margins and future P/E as the main factors behind this revision. Analyst Commentary Analysts lifting the price target to €20.50 are updating their view on how the market might value Banca Mediolanum, with a clear focus on discount rates, profit margins and the P/E they see as reasonable for the stock.Narrative Update • Feb 25
BMED: Future Returns Will Rely On Margin Resilience And Lower Discount Rate
The analyst price target for Banca Mediolanum has been raised, with the latest move including an increase to €20.50. This reflects updated fair value assumptions of €21.55, a lower discount rate, and largely unchanged views on revenue growth, profit margins, and future P/E.Narrative Update • Feb 10
BMED: Future Returns Will Depend On Margin Resilience And Earnings Multiple Stability
Analysts have lifted their price target on Banca Mediolanum to about €21.39 from €20.69, reflecting updated views on fair value, discount rate, revenue growth and profit margins, supported by recent Street research that includes a higher €20 target from JPMorgan. Analyst Commentary Bullish Takeaways Bullish analysts view the lift in the price target toward about €21.39, in line with the new €20 level from JPMorgan, as support for a higher fair value range based on updated assumptions around earnings power and profitability.Narrative Update • Jan 26
BMED: Future Returns Will Hinge On Margin Resilience And Stable P/E Expectations
Analysts have nudged their fair value estimate for Banca Mediolanum to about €20.69 from €19.84, reflecting updated assumptions on revenue growth, profit margins and future P/E that are broadly in line with recent Street research, including a higher €20 price target from major firms. Analyst Commentary Bullish Takeaways Bullish analysts see the new €20 target from JPMorgan as broadly consistent with the updated fair value estimate of €20.69, which they view as confirmation that the stock is roughly aligned with current Street thinking.Narrative Update • Jan 11
BMED: Future Returns Will Depend On Margin Durability And Higher Earnings Multiple
Analysts have lifted their price target on Banca Mediolanum to €20 from €18, reflecting updated views on the discount rate, profit margin and future P/E assumptions. Analyst Commentary Bullish Takeaways Bullish analysts view the higher €20 price target as aligned with updated assumptions on discount rate and profit margins, which they see as better reflecting the bank's earnings profile.Narrative Update • Dec 23
BMED: Future Upside Will Depend On Margin Resilience And Revenue Headwinds
Analysts have nudged their price target for Banca Mediolanum slightly higher to EUR 19.84 from EUR 19.64, citing the recent Street research move toward a EUR 20 target and modest improvements in profit margin expectations, despite softer revenue growth assumptions. Analyst Commentary Bullish Takeaways Bullish analysts highlight that the revised EUR 20 price target implies additional upside from current levels, reflecting confidence in the bank's ability to execute on its strategic plan.Narrative Update • Dec 09
BMED: Future Upside Will Rely On Sustained Profitability And Execution
Analysts have nudged their price target for Banca Mediolanum slightly higher to EUR 19.64 from EUR 19.51, citing a modest improvement in projected profitability and aligning more closely with recent Street-level target increases to around EUR 20. Analyst Commentary Recent Street research reflects a generally constructive view on Banca Mediolanum, with bullish analysts pointing to an improved risk reward profile following the latest price target revisions.Narrative Update • Nov 25
BMED: Future Gains Will Depend On Execution Following 50% YTD Rally
The analyst price target for Banca Mediolanum has risen from €18.89 to €19.51. This reflects analysts' increased confidence based on recent price target upgrades and sustained revenue growth expectations.Narrative Update • Nov 10
BMED: Future Share Price Momentum Will Balance Recent 50% Gain With Efficiency Hopes
The analyst price target for Banca Mediolanum has risen from €17.93 to €18.89, as analysts cite slight improvements in profit margin and a lowered discount rate, which support a more favorable valuation. Analyst Commentary Recent analyst coverage on Banca Mediolanum reflects a mix of optimistic and cautious perspectives, highlighting both potential upside and factors that may temper expectations.Narrative Update • Oct 27
Rising Share Price And Sector Pressures Will Challenge Earnings Sustainability
Banca Mediolanum's analyst price target has increased slightly from €17.70 to €17.93, as analysts point to continued strong fundamentals and recent upward price target revisions, even as growth expectations are moderating. Analyst Commentary Recent research coverage has highlighted a balance of bullish optimism and cautious perspectives regarding Banca Mediolanum's outlook.Narrative Update • Oct 13
Italian And Spanish Headwinds Will Erode Profit Margins
Banca Mediolanum's analyst price target has increased from €17.38 to €17.70, reflecting analysts' confidence in its slightly improved profit margin and updated valuation metrics. Analyst Commentary Recent commentary from the Street highlights diverging perspectives on Banca Mediolanum's valuation and prospects, with both bullish and bearish analysts outlining key factors shaping their respective stances.Narrative Update • Sep 20
Italian And Spanish Headwinds Will Erode Profit Margins
Analysts have modestly increased Banca Mediolanum’s price target to €17.38, citing continued earnings momentum, robust capital generation, and resilient operating performance, but remain somewhat cautious on near-term upside following the stock’s strong rally. Analyst Commentary Bullish analysts cite continued earnings momentum and robust capital generation, supporting incremental target price increases.Narrative Update • Sep 05
Italian And Spanish Headwinds Will Erode Profit Margins
Analysts maintain a positive outlook on Banca Mediolanum due to robust share price momentum, but valuation concerns following the stock’s rally have limited further upside, resulting in an unchanged consensus price target of €17.11. Analyst Commentary Bullish analysts cited strong share price momentum, with the stock up 50% year-to-date.Analysis Article • Jul 02
Should You Be Adding Banca Mediolanum (BIT:BMED) To Your Watchlist Today?
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...
New Narrative • Nov 25
Strong Earnings Growth Amid Market Challenges May Boost Valuation Despite Shrinking Margins
Strategic initiatives and market alignment are expected to boost net inflows, managed assets, and recurring commission income, supporting sustainable revenue growth.Shareholder Returns
| BMED | IT Diversified Financial | IT Market | |
|---|---|---|---|
| 7D | -2.0% | -2.5% | -2.7% |
| 1Y | 48.1% | 34.8% | 23.3% |
Return vs Industry: BMED exceeded the Italian Diversified Financial industry which returned 34.8% over the past year.
Return vs Market: BMED exceeded the Italian Market which returned 23.3% over the past year.
Price Volatility
| BMED volatility | |
|---|---|
| BMED Average Weekly Movement | 3.8% |
| Diversified Financial Industry Average Movement | 4.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in IT Market | 8.6% |
| 10% least volatile stocks in IT Market | 3.0% |
Stable Share Price: BMED has not had significant price volatility in the past 3 months compared to the Italian market.
Volatility Over Time: BMED's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1982 | 4,138 | Massimo Doris | www.bancamediolanum.it |
Banca Mediolanum S.p.A. engages in the provision of various banking products and services in Italy. It offers current accounts; deposits products; and mortgage and personal loans. The company also provides credit cards, debit cards, and prepaid cards; investment products, such as mutual funds, unit linked policies, investment strategies, trading services, asset management services, social security, and bond issues and certificates; and insurance policies, including health and personal, life, serious illness, and autonomy protection, as well as protection assistance, and home and family protection.
Banca Mediolanum S.p.A. Fundamentals Summary
| BMED fundamental statistics | |
|---|---|
| Market cap | €15.97b |
| Earnings (TTM) | €1.27b |
| Revenue (TTM) | €2.44b |
12.6x
P/E Ratio6.5x
P/S RatioIs BMED overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BMED income statement (TTM) | |
|---|---|
| Revenue | €2.44b |
| Cost of Revenue | €5.79m |
| Gross Profit | €2.44b |
| Other Expenses | €1.16b |
| Earnings | €1.27b |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
Jul 30, 2026
| Earnings per share (EPS) | 1.72 |
| Gross Margin | 99.76% |
| Net Profit Margin | 52.06% |
| Debt/Equity Ratio | 38.8% |
How did BMED perform over the long term?
See historical performance and comparisonDividends
6.0%
Current Dividend Yield75%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/28 06:35 |
| End of Day Share Price | 2026/06/26 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Banca Mediolanum S.p.A. is covered by 18 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Gabriele Venturi | Banca Akros S.p.A. (ESN) |
| Giorgia Ariano | Banca Akros S.p.A. (ESN) |
| Enrico Esposti | Banca Akros S.p.A. (ESN) |